Biodesix (BDSX) Revenue (2019 - 2026)

Biodesix (BDSX) has reported Revenue for 8 consecutive years, with $25.6 million the latest figure, recorded in Q1 2026.

• Revenue for Q1 2026 came in at $25.6 million, up 42.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.1 million (up 29.05% YoY), and the FY2025 annual result was $88.5 million, up 24.08% from the prior year.
• Revenue was $25.6 million for Q1 2026 at Biodesix, down from $28.8 million in the prior quarter.
• Over five years, Revenue peaked at $28.8 million in Q4 2025 and troughed at $6.5 million in Q1 2022.
• Average Revenue over 5 years is $16.0 million, with a median of $14.8 million recorded in 2024.
• The widest YoY moves for Revenue: up 70.07% in 2022, down 77.32% in 2022.
• Over 5 years, Revenue stood at $9.6 million in 2022, then jumped by 52.68% to $14.7 million in 2023, then surged by 39.28% to $20.4 million in 2024, then surged by 40.76% to $28.8 million in 2025, then slipped by 11.13% to $25.6 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $25.6 million in Q1 2026, $28.8 million in Q4 2025, and $21.8 million in Q3 2025.